XML 19 R8.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements Of Cash Flows (Parenthetical) (USD $)
Mar. 31, 2010
Apr. 20, 2007
Series E Preferred Stock [Member]
Carbon Nanotechnologies, Inc [Member]
Sep. 30, 2010
Series A Preferred Stock [Member]
Calando Pharmaceuticals, Inc [Member]
Sep. 22, 2009
Series A Preferred Stock [Member]
Unidym, Inc [Member]
Jun. 11, 2009
Series A Preferred Stock [Member]
Unidym, Inc [Member]
Nov. 30, 2010
Series C Preferred Stock [Member]
Unidym, Inc [Member]
Jun. 25, 2009
Series C Preferred Stock [Member]
Unidym, Inc [Member]
Sep. 30, 2009
Series C-1 Preferred Stock [Member]
Unidym, Inc [Member]
Mar. 23, 2005
Insert Therapeutics, Inc [Member]
Nov. 30, 2010
Calando Pharmaceuticals, Inc [Member]
Feb. 28, 2010
Calando Pharmaceuticals, Inc [Member]
Mar. 31, 2006
Calando Pharmaceuticals, Inc [Member]
Sep. 28, 2009
Unidym, Inc [Member]
Apr. 23, 2008
Unidym, Inc [Member]
Apr. 29, 2008
MASA Energy LLC [Member]
Aug. 08, 2008
Nanoconduction, Inc [Member]
Purchase of common shares     1,562.5           7,375,000 2,850,000 200,000 964,000   200,000    
Common stock, shares issued   1,431,222   91,495 1,324,625 153,176 1,944,444 277,778 502,260 1,140,000 80,000 208,382 642,273 70,547 105,049 114,115
Common stock value   $ 5,400,000   $ 46,662 $ 688,802 $ 47,485 $ 972,222 $ 186,111 $ 2,000,000 $ 706,800   $ 1,077,333 $ 398,209   $ 310,000 $ 250,000
Value of common stock purchased                       1,928,000   200,000 560,000  
Stock purchased by cash                       $ 850,667     $ 250,000  
Warrants issued     3,906,250             240,000 24,000          
Warrants purchased                   600,000 60,000          
Common stock exercise value     $ 0.50               $ 0.50          
Warrants exercised 247,880                              
Stock issued against warrants 128,707